CRABP2 and neoplasm: The results showed that CRABP2 silencing alone had no significant effect on tumor growth, but combined with DDP treatment, CRABP2 silencing could significantly inhibit tumor growth rate in mice (Fig. 7A), and the volume of tumor treated with knocked CRABP2 combined with DDP was the smallest (Fig. 7B).